Kymera Therapeutics (KYMR) Current Deferred Revenue (2019 - 2025)
Kymera Therapeutics' Current Deferred Revenue came in at $22.93 million for Q4 2025, up 68.9% from $13.58 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Going back to Q4 2019, Kymera Therapeutics' Current Deferred Revenue data covers 23 quarters.
- Current Deferred Revenue carries a five-year compound annual growth rate of -24.4% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $13.58 million in FY2024 (-64.2%), $37.88 million in FY2023 (+7.4%), $35.26 million in FY2022 (-42.9%) and $61.74 million in FY2021 (-33.3%).
- The five-year range for quarterly Current Deferred Revenue is $11.48 million (Q1 2025) to $87.91 million (Q1 2021).
- Year-over-year, Current Deferred Revenue has increased for three consecutive quarters, with growth averaging 0.2% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q2 2025 (growth of 107.7%), and the weakest in Q4 2024 (a decline of 64.2%).
- Business Quant data shows KYMR's Current Deferred Revenue at $23.28 million (Q3 2025), $40 million (Q2 2025) and $11.48 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Kymera Therapeutics | 11.09 Bn | 8.39 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22.93 Mn |
| Sep 30, 2025 | 23.28 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 13.58 Mn |
| Sep 30, 2024 | 20.02 Mn |
| Jun 30, 2024 | 19.26 Mn |
| Mar 31, 2024 | 22.61 Mn |
| Dec 31, 2023 | 37.88 Mn |
| Sep 30, 2023 | 27.35 Mn |
| Jun 30, 2023 | 24.30 Mn |
| Mar 31, 2023 | 32.25 Mn |
| Dec 31, 2022 | 35.26 Mn |
| Sep 30, 2022 | 55.78 Mn |
| Jun 30, 2022 | 59.46 Mn |
| Mar 31, 2022 | 60.85 Mn |
| Dec 31, 2021 | 61.74 Mn |
| Sep 30, 2021 | 66.23 Mn |
| Jun 30, 2021 | 82.26 Mn |
| Mar 31, 2021 | 87.91 Mn |
API Access
Kymera Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();